M. M. Schittenhelm - Cantonal Hosp St Gallen, Univ Hosp Tubingen

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 31 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

P10.34.b oncogenic aspp2kappa(k), a dominant-negative isoform of the apoptosis stimulating protein of p53-2 (aspp2) promotes classical hallmarks of cancer in glioblastoma

M Hafner,A Ruiba,L Kampa,I Sommer, A Ahrens, V Kälin, A Zeitlberger,K Buchauer,L Plasswilm,T Hundsberger,M Neidert,M M Schittenhelm,K M Kampa-Schittenhelm

Neuro-Oncologyno. Supplement_2 (2023): ii70-ii71

引用0浏览0引用

Detection and characterisation of a dominant-negative, oncogenic splicing variant of the Apoptosis-StimulatingProtein of p53-2 (ASPP2) in triple negative breast cancer (TNBC)

A. -L Ahrens,V Tsintari,W. Jochum,M. M. Schittenhelm,K. M. Kampa-Schittenhelm

ONCOLOGY RESEARCH AND TREATMENT（2021）

引用0浏览0引用

First in-class evaluation of type B Polycyclic Polyprenylated Acylphloroglucinols (PPAP) in acute myeloid leukemia (AML) reveals potent antitumor activities

Puig C. Moreno,F. Izzo, F. Kraus,P. Peslalz, P. L. Rossberg,B. Plietker,M. M. Schittenhelm,K. M. Kampa-Schittenhelm

ONCOLOGY RESEARCH AND TREATMENT（2021）

引用0浏览0引用

Epigenetic activation of O-linked β-N-acetylglucosamine transferase overrides the differentiation blockage in acute leukemia

K M Kampa-Schittenhelm, T Haverkamp,M Bonin,V Tsintari,H J Bühring,L Haeusser,G Blumenstock, S T Dreher,T Ganief,F Akmut,B Illing,U A Mau-Holzmann,I Bonzheim, E Schleicher,W Vogel,M M Schittenhelm

EBioMedicine（2020）

引用8浏览0WOS引用

Detection and characterization of a dominant-negative oncogenic splice variant of the Apoptosis-Stimulating Protein of p53-2 (ASPP2) in colorectal cancer (CRC)

I Rieger,V Tsintari,M. M. Schittenhelm,K. M. Kampa-Schittenhelm

ONCOLOGY RESEARCH AND TREATMENTno. SUPnan (2018): 286.0-287

引用0浏览0引用

Non-psychotropic cannabidiol (CBD) induces differentiation of leukemic blasts

L. Haeusser,W. Vogel,K. M. Kampa-Schittenhelm,M. M. Schittenhelm

ONCOLOGY RESEARCH AND TREATMENTno. SUPnan (2018): 78-78

引用0浏览0引用

Synthetic lethality via targeting proapoptotic ASPPs (Apoptosis Stimulating Proteins of TP53) and antiapoptotic BCL-XL results in highly antileukemic efficacy in AML

M. Wiecken, L. Kanz,M. M. Schittenhelm,K. M. Kampa-Schittenhelm

ONCOLOGY RESEARCH AND TREATMENTno. SUPnan (2018): 76-76

引用0浏览0引用

ASPP2k, an oncogenic splice variant of the Apoptosis-Stimulating Protein of p53-2 (ASPP2) promotes proliferation and invasion in sarcoma

V Tsintari, B. Walter,C. Hinterleitner,M. M. Schittenhelm,K. M. Kampa-Schittenhelm

ONCOLOGY RESEARCH AND TREATMENTno. SUPnan (2018): 125-125

引用0浏览0引用

Characterization of the role of LIN9 in acute myeloid leukemia

S. -T. Dreher,L. Haeusser,M. M. Schittenhelm,K. M. Kampa-Schittenhelm

ONCOLOGY RESEARCH AND TREATMENTno. SUPnan (2018): 53-53

引用0浏览0引用

Dose-reduced, interval-intensified decitabine is effective in patients with highly dynamic acute myeloid leukemia (AML)

M. M. Schittenhelm,K. M. Kampa-Schittenhelm,H. Salih, L. Kanz,M. Soekler

ONCOLOGY RESEARCH AND TREATMENT（2017）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn